Can an antidepressant shield the brain from Parkinson's damage?
NCT ID NCT04497168
First seen Jan 29, 2026 · Last updated May 24, 2026 · Updated 16 times
Summary
This study tested whether taking citalopram for 26 months could slow the buildup of harmful amyloid plaques in a brain area important for vision and thinking in people with Parkinson's disease. 58 older adults with Parkinson's took either citalopram or a placebo. Researchers used brain scans and thinking tests to measure changes. The goal was to see if citalopram could protect the brain from further decline.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.